CA2715575A1 - Method to detect candida species - Google Patents

Method to detect candida species Download PDF

Info

Publication number
CA2715575A1
CA2715575A1 CA2715575A CA2715575A CA2715575A1 CA 2715575 A1 CA2715575 A1 CA 2715575A1 CA 2715575 A CA2715575 A CA 2715575A CA 2715575 A CA2715575 A CA 2715575A CA 2715575 A1 CA2715575 A1 CA 2715575A1
Authority
CA
Canada
Prior art keywords
primers
species
group
bacterial
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2715575A
Other languages
French (fr)
Other versions
CA2715575C (en
Inventor
Michel G. Bergeron
Francois J. Picard
Marc Ouellette
Paul H. Roy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GeneOhm Sciences Canada Inc
Original Assignee
GeneOhm Sciences Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GeneOhm Sciences Canada Inc filed Critical GeneOhm Sciences Canada Inc
Priority to CA2790915A priority Critical patent/CA2790915C/en
Priority to CA2789369A priority patent/CA2789369C/en
Publication of CA2715575A1 publication Critical patent/CA2715575A1/en
Application granted granted Critical
Publication of CA2715575C publication Critical patent/CA2715575C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26Klebsiella (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Abstract

DNA-based methods employing amplification primers or probes for detecting, identifying, and quantifying in a test sample DNA from (i) any bacterium, (ii) the species Streptococcus agalactiae, Staphylococcus saprophyticus, Enterococcus faecium, Neisseria meningitidis, Listeria monocytogenes and Candida albicans, and (iii) any species of the genera Streptococcus, Staphylococcus, Enterococcus, Neisseria and Candida are disclosed. DNA-based methods employing amplification primers or probes for detecting, identifying, and quantifying in a test sample antibiotic resistance genes selected from the group consisting of bla tem , bla rob , bla shv , bla oxa , blaZ, aadB, aacC1, aacC2, aacC3, aacA4, aac6'-IIa, ermA, ermB, ermC, mecA, vanA, vanB, vanC, satA, aac(6)-aph(2"), aad(6'), vat, vga, msrA, sul and int are also disclosed. The above microbial species, genera and resistance genes arc all clinically relevant and commonly encountered in a variety of clinical specimens. These DNA-based assays are rapid, accurate and can be used in clinical microbiology laboratories for routine diagnosis. These novel diagnostic tools should be useful to improve the speed and accuracy of diagnosis of microbial infections, thereby allowing more effective treatments. Diagnostic kits for (i) the universal detection and quantification of bacteria, and/or (ii) the detection, identification and quantification of the above-mentioned bacterial and fungal species and/or genera, and/or (iii) the detection, identification and quantification of the above-mentioned antibiotic resistance genes arc also claimed.

Claims (47)

What is claimed is:
1. A method using probes and/or amplification primers which are specific, ubiquitous and sensitive for determining the presence and/or amount of nucleic acids:
- from a bacterial antibiotic resistance gene selected from the group consisting of bla tem, bla shv, bla rob, bla oxa, blaZ, aadB, aacC1, aacC2, aacC3, aac6'-IIa, aacA4, aad(6), vanA, vanB, vanC, msrA, satA, aac(6)-aph(2"), vat, vga, ermA, ermB, ermC, mecA, int and sul, and - from specific bacterial and fungal species selected from the group consisting of Enterococcus faecium, Listeria monocytogenes, Neisseria meningitidis, Staphylococcus saprophyticus, Streptococcus agalactiae, Candida albicans, Enterococcus species, Neisseria species, Staphylococcus species, Streptococcus species and Candida species, in any sample suspected of containing said bacterial and/or fungal nucleic acids, wherein each of said nucleic acid or variant or part thereof comprises a selected target region hybridizable with said probes or primers;

said method comprising the following steps: contacting said sample with said probes or primers and detecting the presence and/or amount of hybridized probes or amplified products as an indication of the presence and/or amount of said specific bacterial and/or fungal species and bacterial antibiotic resistance genes.
2. A method according to claim 1, which further makes use of probes and/or primers which are specific, ubiquitous and sensitive for determining the presence and/or amount of nucleic acids from any bacterium or fungus.
3. The method of claim 1, which is performed directly from a test sample.
4. The method of claim 1, which is performed directly from a test sample consisting of a bacterial and/or fungal culture or suspension.
5. The method of claim 1, wherein said nucleic acids are all detected under uniform hybridization or amplification conditions.
6. The method of claim 1, wherein said nucleic acids are amplified by a method selected from the group consisting of:

a) polymerase chain reaction (PCR), b) ligase chain reaction (LCR), c) nucleic acid sequence-based amplification (NASBA), d) self-sustained sequence replication (3SR), e) strand displacement amplification (SDA), f) branched DNA signal amplification (bDNA), g) transcription-mediated amplification (TMA), h) cycling probe technology (CPT), i) nested PCR, and j) multiplex PCR.
7. The method of claim 6, wherein said nucleic acids are amplified by PCR.
8. The method of claim 7, wherein the PCR protocol achieves within one hour under uniform amplification conditions the determination of the presence of said nucleic acids by performing for each amplification cycle an annealing step of thirty seconds at 45-55°C and a denaturation step of only one second at 95°C without any time specifically allowed to an elongation step.
9. A method for the detection, identification and/or quantification of a microorganism selected from the group consisting of Enterococcus faecium, Listeria monocytogenes, Neisseria meningitidis, Staphylococcus saprophyticus, Streptococcus agalactiae, Candida albicans, Enterococcus species, Neisseria species, Staphylococcus species, Streptococcus species and Candida species, directly from a test sample or from bacterial and/or fungal cultures, which comprises the following steps:

a) depositing and fixing on an inert support or leaving in solution the said microorganism DNA of the sample or of a substantially homogeneous population of said microorganism isolated from this sample, or inoculating said sample or said substantially homogeneous population of microorganism isolated from this sample on an inert support, and lysing in situ said inoculated sample or said isolated microorganism to release the said microorganism DNA, said microorganism DNA being made in a substantially single-stranded form;
b) contacting said single-stranded DNA with a probe, said probe comprising at least one single-stranded nucleic acid which nucleotide sequence is selected from the group consisting of SEQ ID NOs: 26, 27, 28, 29, 30, 120, 131 to 134, 31, 140 to 143, 32 to 36, 120 to 124, a sequence complementary thereof, a part thereof having at least 12 nucleotides in length, and a variant thereof, which specifically and ubiquitously anneals with strains or representatives of Enterococcus faecium, Listeria monocytogenes, Neisseria meningitidis, Staphylococcus saprophyticus, Streptococcus agalactiae, Candida albicans, Enterococcus species, Neisseria species, Staphylococcus species, Streptococcus species and Candida species, respectively, under conditions such that the nucleic acid of said probe can selectively hybridize with said microorganism DNA, whereby a hybridization complex is formed; and c) detecting the presence of said hybridization complex on said inert support or in said solution as an indication of the presence and/or amount of said microorganism, in said test sample.
10. A method for detecting the presence and/or amount of a microorganism selected from the group consisting of Enterococcus faecium, Listeria monocytogenes, Neisseria meningitidis, Staphylococcus saprophyticus, Streptococcus agalactiae, Candida albicans, Enterococcus species, Neisseria species, Staphylococcus species, Streptococcus species and Candida species, in a test sample which comprises the following steps:

a) treating said sample with an aqueous solution containing at least one pair of oligonucleotide primers having at least 12 nucleotides in length, one of said primers being capable of hybridizing selectively with one of the two complementary strands of said microorganism DNA that contains a target sequence, and the other of said primers being capable of hybridizing with the other of said strands so as to form an extension product which contains the target sequence as a template, said at least one pair of primers being chosen from a nucleotide sequence within the group consisting of SEQ ID NOs: 26, 27, 28, 29, 30, 120, 131 to 134, 31, 140 to 143, 32 to 36, 120 to 124, respectively with regard to said microorganism, a sequence complementary thereof, and a variant thereof;

b) synthesizing an extension product of each of said primers, said extension product containing the target sequence, and amplifying said target sequence, if any, to a detectable level; and c) detecting the presence and/or amount of said amplified target sequence as an indication of the presence and/or amount of said microorganisms, in said test sample.
11. The method of claim 10, wherein said pair of primers is defined in SEQ ID
NOs:
1 and 2, 3 and 4, 5 and 6, 7 and 8, 9 and 10, 11 and 12, 13 and 14, 15 and 16, 17 to 20, 21 and 22, respectively, for each of Enterococcus faecium, Listeria monocytogenes, Neisseria meningitidis, Staphylococcus seprophyticus, Streptococcus aga/actiae, Candida albicans, Enterococcus species, Neisseria species, Staphylococcus species and Streptococcus species.
12. A method for detecting the presence and/or amount of any bacterium directly from a test sample or a bacterial culture, which comprises the following steps:

a) depositing and fixing on an inert support or leaving in solution the bacterial DNA of the sample or of a substantially homogeneous population of bacteria isolated from this sample, or inoculating said sample or said substantially homogeneous population of bacteria isolated from this sample on an inert support, and lysing in situ said inoculated sample or isolated bacteria to release the bacterial DNA, said bacterial DNA being made in a substantially single-stranded form;

b) contacting said single-stranded DNA with a probe, said probe comprising at least one single-stranded nucleic acid which nucleotide sequence is selected from the group consisting of SEQ ID NOs: 118, 119, 125 to 171, a sequence complementary thereof, a part thereof having at least 12 nucleotides in length, and a variant thereof, which specifically and ubiquitously anneals with strains or representatives of any bacterial species, under conditions such that the nucleic acid of said probe can selectively hybridize with said bacterial DNA, whereby a hybridization complex is formed; and c) detecting the presence of said hybridization complex on said inert support or in said solution as an indication of the presence and/or amount of any bacterium in said test sample.
13. A method for detecting the presence and/or amount of any bacterium in a test sample which comprises the following steps:

a) treating said sample with an aqueous solution containing at least one pair of oligonucleotide primers having at least 12 nucleotides in length, one of said primers being capable of hybridizing selectively with one of the two complementary strands of any bacterial DNA that contains a target sequence, and the other of said primers being capable of hybridizing with the other of said strands so as to form an extension product which contains the target sequence as a template, said at least one pair of primers being chosen from a nucleotide sequence within the group consisting of SEQ ID
NO:
118, 119, 125 to 171, a sequence complementary thereof, and a variant thereof;

b) synthesizing an extension product of each of said primers, said extension product containing the target sequence, and amplifying said target sequence, if any, to a detectable level; and c) detecting the presence and/or amount of said amplified target sequence as an indication of the presence and/or amount of any bacterium in said test sample.
14. The method of claim 13, wherein said pair of primers is defined in SEQ ID
NOs:
23 and 24.
15. A method for obtaining tuf sequences from any bacterium directly from a test sample or a bacterial culture, which comprises the following steps:

a) treating said sample with an aqueous solution containing a pair of primers having a sequence selected within the nucleotide sequences defined in SEQ ID
NOs:
107 and 108, a part thereof having at least 12 nucleotides in length, a sequence complementary thereof, and a variant thereof, one of said primers being capable of hybridizing selectively with one of the two complementary strands of said bacterial tuf gene that contains a target sequence, and the other of said primers being capable of hybridizing with the other of said strands so as to form an extension product which contains the target sequence as a template;

b) synthesizing an extension product of each of said primers, said extension product containing the target sequence, and amplifying said target sequence, if any, to a detectable level; and c) detecting the presence and/or amount of said amplified target sequence; and d) determining the nucleotide sequence of the said amplified target sequence by using any DNA sequencing method.
16. A method for detecting the presence and/or amount of any fungus directly from a test sample or a fungal culture, which comprises the following steps:

a) depositing and fixing on an inert support or leaving in solution the fungal DNA
of the sample or of a substantially homogeneous population of fungi isolated from this sample, or inoculating said sample or said substantially homogeneous population of fungi isolated from this sample on an inert support, and lysing in situ said inoculated sample or isolated fungi to release the fungal DNA, said fungal DNA being made in a substantially single-stranded form;

b) contacting said single-stranded DNA with a probe, said probe comprising at least one single-stranded nucleotide sequence selected from the group consisting of SEQ ID NOs: 120 to 124, a sequence complementary thereof, a part thereof having at least 12 nucleotides in length, and a variant thereof, which specifically and ubiquitously anneals with strains or representatives of any fungus, under conditions such that the nucleic acid of said probe can selectively hybridize with said fungal DNA, whereby a hybridization complex is formed; and c) detecting the presence of said hybridization complex on said inert support or in said solution as an indication of the presence and/or amount of any fungus in said test sample.
17. A method for detecting the presence and/or amount of any fungus in a test sample which comprises the following steps:

a) treating said sample with an aqueous solution containing at least one pair of oligonucleotide primers having at least 12 nucleotides in length, one of said primers being capable of hybridizing selectively with one of the two complementary strands of any fungal DNA that contains a target sequence, and the other of said primers being capable of hybridizing with the other of said strands so as to form an extension product which contains the target sequence as a template, said at least one pair of primers being chosen from a nucleotide sequence within the group consisting of SEQ ID
NOs:
120 to 124, a sequence complementary thereof, and a variant thereof;

b) synthesizing an extension product of each of said primers, said extension product containing the target sequence, and amplifying said target sequence, if any, to a detectable level; and c) detecting the presence and/or amount of said amplified target sequence as an indication of the presence and/or amount of any fungus in said test sample.
18. A method for obtaining tuf sequences from any fungus directly from a test sample or a fungal culture, which comprises the following steps:

a) treating said sample with an aqueous solution containing a pair of primers having a sequence selected within the nucleotide sequence defined in SEQ ID
NOs:
109 and 172, a part thereof having at least 12 nucleotides in length, a sequence complementary thereof, and a variant thereof, one of said primers being capable of hybridizing selectively with one of the two complementary strands of said fungal tuf gene that contains a target sequence, and the other of said primers being capable of hybridizing with the other of said strands so as to form an extension product which contains the target sequence as a template;

b) synthesizing an extension product of each of said primers, said extension product containing the target sequence, and amplifying said target sequence, if any, to a detectable level; and c) detecting the presence and/or amount of said amplified target sequence; and d) determining the nucleotide sequence of the said amplified target sequence by using any DNA sequencing method.
19. A method as defined in claim 1, which comprises the evaluation of the presence of a bacterial resistance mediated by a bacterial antibiotic resistance gene selected from the group consisting of bla oxa, blaZ, aac6'-IIa, ermA, ermB, ermC, vanB, vanC, directly from a test sample or a bacterial culture, which comprises the following steps:

a) depositing and fixing on an inert support or leaving in solution the bacterial DNA of the sample or of a substantially homogeneous population of bacteria isolated from this sample, or inoculating said sample or said substantially homogeneous population of bacteria isolated from this sample on an inert support, and lysing in situ said inoculated sample or isolated bacteria to release the bacterial DNA, said bacterial DNA being made in a substantially single-stranded form;

b) contacting said single-stranded DNA with a probe, said probe comprising at least one single-stranded nucleotide sequence having at least 12 nucleotide in length is selected from the group consisting of SEQ ID NOs: 110, 111, 112, 113, 114 115, 116, 117, a sequence complementary thereof, and a variant thereof, which specifically hybridizes with said bacterial antibiotic resistance gene, respectively; and c) detecting the presence of a hybridization complex as an indication of a bacterial resistance mediated by said one of said bacterial antibiotic resistance genes.
20. A method as defined in claim 1, which comprises the evaluation of the presence of a bacterial resistance mediated by a bacterial antibiotic resistance gene selected from the group consisting of bla oxa, blaZ, aac6'-IIa, ermA, ermB, ermC, vanB, vanC, directly from a test sample or a bacterial culture, which comprises the following steps:

a) treating said sample with an aqueous solution containing at least one pair of primers having at least 12 nucleotides in length, one of said primers being capable of hybridizing selectively with one of the two complementary strands of said bacterial antibiotic resistance gene that contains a target sequence, and the other of said primers being capable of hybridizing with the other of said strands so as to form an extension product which contains the target sequence as a template, said at least one pair of primers being chosen from a nucleotide sequence within the group consisting of SEQ ID NOs: 110, 111, 112, 113, 114, 115, 116, 117, respectively with regard to said bacterial antibiotic resistance gene, a sequence complementary thereof, and a variant thereof;

b) synthesizing an extension product of each of said primers, said extension product containing the target sequence, and amplifying said target sequence, if any, to a detectable level; and c) detecting the presence and/or amount of said amplified target sequence as an indication of a bacterial resistance mediated by one of said bacterial antibiotic resistance genes.
21. A method as defined in claim 1, which comprises the evaluation of the presence of a bacterial resistance gene selected from the group consisting of bla tem, bla shv, bla rob, bla oxa, blaZ, aadB, aacC1, aacC2, aacC3, aac6-IIa, aacA4, aad(6'), vanA, vanB, vanC, msrA, satA, aac(6')-aph(2"), vat, vga, ermA, ermB, ermC, mecA, int and sul, directly from a test sample or a bacterial culture, which comprises the following steps:

a) treating said sample with an aqueous solution containing at least one pair of primers having a sequence selected in the group consisting of SEQ ID NOs: 37 to 40, 41 to 44, 45 to 48, 49 and 50, 51 and 52, 53 and 54, 55 and 56, 57 and 58, 59 to 60, 61 to 64, 65 and 66, 173 and 174, 67 to 70, 71 to 74, 75 and 76, 77 to 80, 81 and 82, 83 to 86, 87 and 88, 89 and 90, 91 and 92, 93 and 94, 95 and 96, 97 and 98, 99 to 102, 103 to 106, a part thereof having at least 12 nucleotides in length, a sequence complementary thereof, a variant thereof, and mixtures thereof, one of said primers of said pair being capable of hybridizing selectively with one of the two complementary strands of its respective bacterial antibiotic resistance gene that contains a target sequence, and the other of said primers of said pairs being capable of hybridizing with the other of said strands so as to form an extension product which contains the target sequence as a template;

b) synthesizing an extension product of each of said primers, said extension product containing the target sequence, and amplifying said target sequence, if any, to a detectable level; and c) detecting the presence and/or amount of said amplified target sequence as an indication of a bacterial resistance mediated by one of said bacterial antibiotic resistance genes.
22. A nucleic acid having the nucleotide sequence of any one of SEQ ID NOs: 26 to 36, 110 to 171, a part thereof, a sequence complementary thereof, and variant thereof which, when in single-stranded form, ubiquitously and specifically hybridizes with a target bacterial or fungal DNA as a probe or as a primer.
23. An oligonucleotide having the nucleotide sequence of any one of SEQ ID
NOs:
1 to 25, 37 to 109, 172 to 174, a part thereof, a sequence complementary thereof, and variant thereof, which ubiquitously and specifically hybridizes with a target bacterial or fungal DNA as a probe or as a primer.
24. A recombinant plasmid comprising a nucleic acid as defined in claim 22.
25. A recombinant host which has been transformed by a recombinant plasmid according to claim 24.
26. A recombinant host according to claim 25 wherein said host is Escherichia coli.
27. A diagnostic kit for the detection and/or quantification of the nucleic acids of any combination of the microbial species and/or genera selected from the group consisting of Enterococcus faecium, Listeria monocytogenes, Neisseria meningitidis, Staphylococcus saprophyticus, Streptococcus agalactiae, Candida albicans, Enterococcus species, Neisseria species, Staphylococcus species, Streptococcus species and Candida species, comprising any suitable combination of probes of at least 12 nucleotides in length selected from the group consisting of SEQ ID
NOs: 26 to 36, 120 to 124, 131 to 134, 140 to 143, sequences complementary thereof, and variants thereof.
28. A diagnostic kit for the detection and/or quantification of the nucleic acids of any combination of the microbial species and/or genera selected from the group consisting of Enterococcus faecium, Listeria monocytogenes, Neisseria meningitidis, Staphylococcus saprophyticus, Streptococcus agalactiae, Candida albicans, Enterococcus species, Neisseria species, Staphylococcus species, Streptococcus species and Candida species, comprising any suitable combination of primers of at least 12 nucleotides in length selected from the group consisting of SEQ ID
NOs: 26 to 36, 120 to 124, 131 to 134, 140 to 143, sequences complementary thereof, and variants thereof.
29. A diagnostic kit for the detection and/or quantification of the nucleic acids of any combination of the microbial species and/or genera selected from the group consisting of Enterococcus faecium, Listeria monocytogenes, Neisseria meningitidis, Staphylococcus saprophyticus, Streptococcus agalactiae, Candida albicans, Enterococcus species, Neisseria species, Staphylococcus species and Streptococcus species, comprising any suitable combination of primers selected from the group consisting of SEQ ID NOs: 1 to 22, parts thereof having at least 12 nucleotides in length, sequences complementary thereof, and variants thereof.
30. A diagnostic kit for the detection and/or quantification of the nucleic acids of any combination of the bacterial resistance genes selected from the group consisting of bla oxa, blaZ, aac6'-IIa, ermA, ermB, ermC, vanB, vanC, comprising any suitable combination of probes of at least 12 nucleotides in length selected from the group consisting of SEQ ID NOs: 110 to 117, sequences complementary thereof, and variants thereof.
31. A diagnostic kit for the detection and/or quantification of the nucleic acids of any combination of the bacterial resistance genes selected from the group consisting of bla oxa, blaZ, aac6'-IIa, ermA, ermB, ermC, vanB, vanC, comprising any suitable combination of primers of at least 12 nucleotides in length selected from the group consisting of SEQ ID NOs: 110 to 117, sequences complementary thereof, and variants thereof.
32. A diagnostic kit for the detection and/or quantification of the nucleic acids of any combination of the bacterial resistance genes selected from the group consisting of bla tem, bla shv, bla rob, bla oxa, blaZ, aadB, aacC1, aacC2, aacC3, aac6'-IIa, aacA4, aad(6'), vanA, vanB, vanC, msrA, satA, aac(6')-aph(2"), vat, vga, ermA, ermB, ermC, mecA, int and sul, comprising any suitable combination of primers selected from the group consisting of SEQ ID NOs: 37 to 106, 173 and 174, a part thereof having at least 12 nucleotides in length, sequences complementary thereof, and variants thereof.
A diagnostic kit for the detection and/or quantification of the nucleic acids of any bacterium and/or fungus, comprising any combination of probes of at least 12 nucleotides in length selected from the group consisting of SEQ ID NOs: 118 to 171, sequences complementary thereof, and variants thereof.
34. A diagnostic kit for the detection and/or quantification of the nucleic acids of any bacterium and/or fungus, comprising any suitable combination of primers of at least 12 nucleotides in length selected from the group consisting of SEQ ID NOs: 118 to 171, sequences complementary thereof, and variants thereof.
35. A diagnostic kit for the detection and/or quantification of the nucleic acids of any bacterium, comprising a pair of primers having a sequence selected within the nucleotide sequence defined in SEQ ID NOs: 23 and 24, parts thereof having at least 12 nucleotides in length, sequences complementary thereof, and variants thereof.
36. A diagnostic kit, as defined in claim 27, further comprising any combination of probes of at least 12 nucleotides in length selected within a nucleotide sequence from the group consisting of SEQ ID NOs: 118 to 171, sequences complementary thereof, and variants thereof, for the simultaneous detection and/or quantification of nucleic acids of any bacterium and/or fungus.
37. A diagnostic kit, as defined in claim 28, further comprising any suitable combination of primers of at least 12 nucleotides in length selected within a nucleotide sequence from the group consisting of SEQ ID NOs: 118 to 171, sequences complementary thereof, and variants thereof, for the simultaneous detection and/or quantification of nucleic acids of any bacterium and/or fungus.
38. A diagnostic kit, as defined in claim 29, further comprising a pair of primers having a sequence selected within the nucleotide sequence defined in SEQ ID
NOs:
23 and 24, parts thereof having at least 12 nucleotides in length, sequences complementary thereof, and variants thereof, for the simultaneous detection and/or quantification of nucleic acids of any bacterium.
39. A diagnostic kit, as defined in claim 27, further comprising any combination of probes of at least 12 nucleotides in length selected within a nucleotide sequence from the group consisting of SEQ ID NOs: 110 to 117, sequences complementary thereof, and variants thereof, for the simultaneous detection and/or quantification of nucleic acids of any bacterial antibiotic resistance gene selected from the group consisting of bla oxa, blaZ, aac6'-IIa, ermA, ermB, ermC, vanB, vanC.
40. A diagnostic kit, as defined in claim 28, further comprising any suitable combination of primers of at least 12 nucleotides in length selected within a nucleotide sequence from the group consisting of SEQ ID NOs: 110 to 117, sequences complementary thereof, and variants thereof, for the simultaneous detection and/or quantification of nucleic acids of any bacterial antibiotic resistance gene selected from the group consisting of bla oxa, blaZ, aac6'-IIa, ermA, ermB, ermC, vanB, vanC.
41. A diagnostic kit, as defined in claim 29, further comprising any suitable combination of primers of at least 12 nucleotides in length selected within a nucleotide sequence from the group consisting of SEQ ID NOs: 37 to 106, 173 and 174, sequences complementary thereof, and variants thereof, for the simultaneous detection and/or quantification of nucleic acids of any bacterial antibiotic resistance gene selected from the group consisting of bla tem, bla rob, bla shv, bla oxa, blaZ, aadB, aacC1, aacC2, aacC3, aacA4, aac6'-IIa, aad(6'), ermA, ermB, ermC, mecA, vanA, vanB, vanC, satA, aac(6')-aph(2"), vat, vga, msrA, sul and int.
42. A diagnostic kit, as defined in claim 30, further comprising any combination of probes of at least 12 nucleotides in length selected within a nucleotide sequence from the group consisting of SEQ ID NOs: 118 to 171, sequences complementary thereof, and variants thereof, for the simultaneous detection and/or quantification of nucleic acids of any bacterium and/or fungus.
43. A diagnostic kit, as defined in claim 31, further comprising any suitable combination of primers of at least 12 nucleotides in length selected within a nucleotide sequence from the group consisting of SEQ ID NOs: 118 to 171, sequences complementary thereof, and variants thereof, for the simultaneous detection and/or quantification of nucleic acids of any bacterium and/or fungus.
44. A diagnostic kit, as defined in claim 32, further comprising a pair of primers having a sequence selected within the nucleotide sequence defined in SEQ ID
NOs:
23 and 24, parts thereof having at least 12 nucleotides in length, sequences complementary thereof, and variants thereof, for the simultaneous detection and/or quantification of nucleic acids of any bacterium.
45. A diagnostic kit, as defined in claim 39, further comprising any combination of probes of at least 12 nucleotides in length selected within a nucleotide sequence from the group consisting of SEQ ID NOs: 118 to 171, sequences complementary thereof, and variants thereof, for the simultaneous detection and/or quantification of nucleic acids of any bacterium and/or fungus.
46. A diagnostic kit, as defined in claim 40, further comprising any suitable combination of primers of at least 12 nucleotides in length selected within a nucleotide sequence from the group consisting of SEQ ID NOs: 118 to 171, sequences complementary thereof, and variants thereof, for the simultaneous detection and/or quantification of nucleic acids of any bacterium and/or fungus.
47. A diagnostic kit, as defined in claim 41, further comprising a pair of primers having a sequence selected within the nucleotide sequence defined in SEQ ID
NOs:
23 and 24, parts thereof having at least 12 nucleotides in length, sequences complementary thereof, and variants thereof, for the simultaneous detection and/or quantification of nucleic acids of any bacterium.
CA2715575A 1996-11-04 1997-11-04 Method to detect candida species Expired - Lifetime CA2715575C (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA2790915A CA2790915C (en) 1996-11-04 1997-11-04 Method, tools and kits for the detection of members of the streptococcus genus
CA2789369A CA2789369C (en) 1996-11-04 1997-11-04 Method, tools and kits for the detection of members of the staphylococcus genus

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/743,637 1996-11-04
US08/743,637 US5994066A (en) 1995-09-11 1996-11-04 Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
CA2270281A CA2270281C (en) 1996-11-04 1997-11-04 Method to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2270281A Division CA2270281C (en) 1996-11-04 1997-11-04 Method to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CA2790915A Division CA2790915C (en) 1996-11-04 1997-11-04 Method, tools and kits for the detection of members of the streptococcus genus
CA2789369A Division CA2789369C (en) 1996-11-04 1997-11-04 Method, tools and kits for the detection of members of the staphylococcus genus

Publications (2)

Publication Number Publication Date
CA2715575A1 true CA2715575A1 (en) 1998-05-14
CA2715575C CA2715575C (en) 2012-12-18

Family

ID=24989560

Family Applications (4)

Application Number Title Priority Date Filing Date
CA2789369A Expired - Lifetime CA2789369C (en) 1996-11-04 1997-11-04 Method, tools and kits for the detection of members of the staphylococcus genus
CA2715575A Expired - Lifetime CA2715575C (en) 1996-11-04 1997-11-04 Method to detect candida species
CA2270281A Expired - Fee Related CA2270281C (en) 1996-11-04 1997-11-04 Method to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens
CA2790915A Expired - Lifetime CA2790915C (en) 1996-11-04 1997-11-04 Method, tools and kits for the detection of members of the streptococcus genus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA2789369A Expired - Lifetime CA2789369C (en) 1996-11-04 1997-11-04 Method, tools and kits for the detection of members of the staphylococcus genus

Family Applications After (2)

Application Number Title Priority Date Filing Date
CA2270281A Expired - Fee Related CA2270281C (en) 1996-11-04 1997-11-04 Method to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens
CA2790915A Expired - Lifetime CA2790915C (en) 1996-11-04 1997-11-04 Method, tools and kits for the detection of members of the streptococcus genus

Country Status (14)

Country Link
US (1) US5994066A (en)
EP (8) EP2336366B1 (en)
JP (3) JP2001504330A (en)
CN (1) CN1248295A (en)
AT (2) ATE434669T1 (en)
AU (1) AU731850B2 (en)
BR (1) BR9713494A (en)
CA (4) CA2789369C (en)
DE (1) DE69739473D1 (en)
DK (1) DK0943009T3 (en)
ES (1) ES2329202T3 (en)
NO (1) NO991976L (en)
NZ (1) NZ335548A (en)
WO (1) WO1998020157A2 (en)

Families Citing this family (184)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020055101A1 (en) * 1995-09-11 2002-05-09 Michel G. Bergeron Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US6905670B2 (en) 1995-03-28 2005-06-14 The General Hospital Corporation Methods of screening compounds useful for prevention of infection or pathogenicity
US6251691B1 (en) 1996-04-25 2001-06-26 Bioarray Solutions, Llc Light-controlled electrokinetic assembly of particles near surfaces
US20100267012A1 (en) 1997-11-04 2010-10-21 Bergeron Michel G Highly conserved genes and their use to generate probes and primers for detection of microorganisms
US20030049636A1 (en) * 1999-05-03 2003-03-13 Bergeron Michel G. Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
US6558901B1 (en) * 1997-05-02 2003-05-06 Biomerieux Vitek Nucleic acid assays
US6570001B1 (en) * 1997-06-20 2003-05-27 Institut Pasteur Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
DE19731292A1 (en) * 1997-07-21 1999-01-28 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Nucleic Acid Molecule, Kit, and Use
US7060458B1 (en) * 1997-08-14 2006-06-13 Wyeth Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
AU763126B2 (en) 1997-11-25 2003-07-10 General Hospital Corporation, The Virulence-associated nucleic acid sequences and uses thereof
DE69933755T2 (en) 1998-01-23 2007-09-13 bioMérieux B.V. EF-TU MRNA AS A MARKER FOR LIVABLE BACTERIA
US6468743B1 (en) * 1998-05-18 2002-10-22 Conagra Grocery Products Company PCR techniques for detecting microbial contaminants in foodstuffs
ES2189459T3 (en) 1998-05-22 2003-07-01 Creatogen Ag DETECTION OF ANTIBIOTIC RESISTORS IN MICROORGANISMS.
GB2362212A (en) * 1998-09-03 2001-11-14 Univ British Columbia Method for the identification and speciation of bacteria of the burkholderia cepacia complex
US6242223B1 (en) * 1998-09-28 2001-06-05 Creighton University Primers for use in detecting beta-lactamases
US6451556B1 (en) 1998-12-21 2002-09-17 Smithkline Beecham Corporation EF-Tu
GB9904804D0 (en) * 1999-03-02 1999-04-28 King S College London Identification of bacteria
US6605709B1 (en) 1999-04-09 2003-08-12 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics
ES2535961T3 (en) 1999-04-09 2015-05-19 Zoetis P&U Llc Attenuated pasteurellaceae bacterium that has a mutation in a virulence gene
US6066461A (en) * 1999-04-12 2000-05-23 Becton Dickinson And Company Amplification and detection of Campylobacter jejuni and Campylobacter coli
US6821770B1 (en) * 1999-05-03 2004-11-23 Gen-Probe Incorporated Polynucleotide matrix-based method of identifying microorganisms
CA2811455C (en) 1999-09-28 2015-12-08 Geneohm Sciences Canada Inc. Nucleic acids and methods for the detection of coagulase-negative staphylococcus
EP1261716A2 (en) * 1999-11-16 2002-12-04 Apollo Biotechnology, Inc. Method for rapid and accurate identification of microorganisms
US20030134293A1 (en) * 1999-11-16 2003-07-17 Zhiping Liu Method for rapid and accurate identification of microorganisms
EP1118677A1 (en) * 2000-01-17 2001-07-25 Novartis AG Oligonucleotides useful in identifying fungicide resistant plant pathogenic fungi
US8076063B2 (en) 2000-02-07 2011-12-13 Illumina, Inc. Multiplexed methylation detection methods
US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions
US7955794B2 (en) 2000-09-21 2011-06-07 Illumina, Inc. Multiplex nucleic acid reactions
US7112716B2 (en) 2000-04-06 2006-09-26 The General Hospital Corporation Methods for screening and identifying host pathogen defense genes
US20020102678A1 (en) * 2000-04-14 2002-08-01 Solh Nevine El Staphylococcal gene, vgaC, conferring resistance to streptogramin A and related compounds
EP1512756B1 (en) * 2000-05-29 2008-03-19 Tosoh Corporation Methods for detection mecA gene of methicillin-resistant Staphylococcus Aureus
US9709559B2 (en) 2000-06-21 2017-07-18 Bioarray Solutions, Ltd. Multianalyte molecular analysis using application-specific random particle arrays
ATE319087T1 (en) 2000-06-21 2006-03-15 Bioarray Solutions Ltd MULTI-ANALYTICAL MOLECULAR ANALYSIS BY USING APPLICATION-SPECIFIC RANDOM PARTICLE ARRAYS
US6261785B1 (en) 2000-07-27 2001-07-17 Becton, Dickinson And Company Amplification and detection of Bordetella pertussis
US20040005555A1 (en) * 2000-08-31 2004-01-08 Rothman Richard E. Molecular diagnosis of bactermia
GB0022017D0 (en) * 2000-09-08 2000-10-25 Univ Dundee Cell assays
US20020086313A1 (en) * 2000-09-25 2002-07-04 Kilbane John J. Application of bioinformatics for direct study of unculturable microorganisms
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US20040121314A1 (en) * 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in containers
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
AU2013231102B2 (en) * 2001-03-02 2016-04-28 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US7718354B2 (en) 2001-03-02 2010-05-18 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
AT410444B (en) * 2001-03-02 2003-04-25 Oesterr Forsch Seibersdorf METHOD FOR DETECTING NUCLEIC ACID MOLECULES
US20040121310A1 (en) * 2002-12-18 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in forensic studies
US20040121313A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in organs for transplantation
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US7052837B2 (en) * 2001-03-13 2006-05-30 The Board Of Trustees Of The University Of Arkansas Histoplasma capsulatum catalase sequences and their use in the detection of Histoplamsa capsulatum and histoplasmosis
DE10124342A1 (en) * 2001-05-18 2002-11-28 Biotecon Diagnostics Gmbh Amplification method for Yersinia pestis and Yersinia pseudotuberculosis, useful for their rapid detection and differentiation, also new primers and probes
CA2348042A1 (en) 2001-06-04 2002-12-04 Ann Huletsky Sequences for detection and identification of methicillin-resistant staphylococcus aureus
US7262063B2 (en) 2001-06-21 2007-08-28 Bio Array Solutions, Ltd. Directed assembly of functional heterostructures
EP1409738A4 (en) * 2001-06-22 2005-03-30 Marshfield Clinic Methods and oligonucleotides for the detection of salmonella sp.,e.coli o157:h7,and listeria monocytogenes
US8073627B2 (en) 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
AU2002354838B2 (en) * 2001-07-19 2007-11-29 Infectio Diagnostic (I.D.I.) Inc. Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection
FR2829148B1 (en) * 2001-09-06 2004-10-15 Univ Aix Marseille Ii MOLECULAR IDENTIFICATION OF STAPHYLOCOCCUS BACTERIA
WO2003034029A2 (en) 2001-10-15 2003-04-24 Bioarray Solutions, Ltd. Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection
US20040002080A1 (en) * 2001-12-14 2004-01-01 Creighton University Primers for use in detecting beta-lactamases
EP1463829A1 (en) * 2001-12-19 2004-10-06 Quantibact A/S A method and a kit for determination of a microbial count
ES2223216B1 (en) * 2002-03-11 2006-04-16 Universidad De Sevilla METHOD FOR THE DETECTION AND QUICK IDENTIFICATION OF SALMONELLA SPP. THROUGH THE CHAIN REACTION OF THE POLYMERASE IN REAL TIME.
US6946267B2 (en) * 2002-03-13 2005-09-20 Dr. Chip Biotechnology Inc. Method for detecting Staphylococcus aureus
US7045291B2 (en) * 2002-05-17 2006-05-16 Creighton University Multiplex PCR for the detection of AmpC beta-lactamase genes
US7108976B2 (en) * 2002-06-17 2006-09-19 Affymetrix, Inc. Complexity management of genomic DNA by locus specific amplification
DE10244456A1 (en) * 2002-09-24 2004-04-15 Hain Lifescience Gmbh Methods for the detection and differentiation of bacteria
US7526114B2 (en) 2002-11-15 2009-04-28 Bioarray Solutions Ltd. Analysis, secure access to, and transmission of array images
US7217519B1 (en) 2002-11-21 2007-05-15 The Board Of Trustees Of The University Of Arkansas Histoplasma capsulatum chitin synthase sequences and their use for detection of Histoplasma capsulatum and histoplasmosis
EP1578399A4 (en) 2002-12-06 2007-11-28 Isis Pharmaceuticals Inc Methods for rapid identification of pathogens in humans and animals
EP1579002B1 (en) 2002-12-13 2014-02-12 Geneohm Sciences Canada, Inc. Methods to verify the efficiency of sample preparation and nucleic acid amplification and/or detection
US8046171B2 (en) 2003-04-18 2011-10-25 Ibis Biosciences, Inc. Methods and apparatus for genetic evaluation
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
CN102304527A (en) * 2003-05-30 2012-01-04 英特塞尔股份公司 Enterococcus antigens
CN1296488C (en) * 2003-06-19 2007-01-24 中国药品生物制品检定所 Detection of main pathogenic microorganism in medicine
DE10339609A1 (en) * 2003-08-28 2005-03-24 Forschungszentrum Karlsruhe Gmbh Oligonucleotide, method and system for the detection of antibiotic resistance-mediating genes in microorganisms by means of real-time PCR
WO2005024053A1 (en) 2003-09-04 2005-03-17 Human Genetic Signatures Pty Ltd Nucleic acid detection assay
US20070248954A1 (en) * 2003-09-10 2007-10-25 Creighton University Primers for Use in Detecting Beta-Lactamases
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20120122103A1 (en) 2003-09-11 2012-05-17 Rangarajan Sampath Compositions for use in identification of bacteria
US20050058985A1 (en) * 2003-09-12 2005-03-17 Dodgson Kirsty Jane Method and kit for identifying vancomycin-resistant enterococcus
US7927796B2 (en) 2003-09-18 2011-04-19 Bioarray Solutions, Ltd. Number coding for identification of subtypes of coded types of solid phase carriers
TW200521436A (en) 2003-09-22 2005-07-01 Bioarray Solutions Ltd Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules
WO2005042763A2 (en) 2003-10-28 2005-05-12 Bioarray Solutions Ltd. Optimization of gene expression analysis using immobilized capture probes
JP2007509629A (en) 2003-10-29 2007-04-19 バイオアレイ ソリューションズ リミテッド Complex nucleic acid analysis by cleavage of double-stranded DNA
US8163895B2 (en) 2003-12-05 2012-04-24 Ibis Biosciences, Inc. Compositions for use in identification of orthopoxviruses
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
US8119336B2 (en) 2004-03-03 2012-02-21 Ibis Biosciences, Inc. Compositions for use in identification of alphaviruses
US8168777B2 (en) 2004-04-29 2012-05-01 Human Genetic Signatures Pty. Ltd. Bisulphite reagent treatment of nucleic acid
WO2005113826A1 (en) * 2004-05-20 2005-12-01 Bioarray Solutions Ltd. Genotyping of multiple loci with pcr for different loci amplification at different temperatures
ES2641832T3 (en) 2004-05-24 2017-11-14 Ibis Biosciences, Inc. Mass spectrometry with selective ion filtration by setting digital thresholds
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
CN100374577C (en) * 2004-06-25 2008-03-12 吴秉铨 Primer for detecting B-family chain coccus special sequence, short-handled gyrate probe, reagent box and method thereof
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
CA2572178A1 (en) * 2004-07-26 2006-03-16 Nanosphere, Inc. Method for distinguishing methicillin resistant s. aureus from methicillin sensitive s. aureus in a mixed culture
EP1778864A4 (en) * 2004-08-02 2008-03-19 Infectio Recherche Inc Capture probe design for efficient hybridisation
US7848889B2 (en) 2004-08-02 2010-12-07 Bioarray Solutions, Ltd. Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
US7309589B2 (en) 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
ATE476439T1 (en) 2004-09-10 2010-08-15 Human Genetic Signatures Pty AMPLIFICATION BLOCKERS COMPRISING INTERCALATING NUCLEIC ACIDS (INA) CONTAINING INTERCALATING PSEUDONUCLEOTIDES (IPN)
FR2875240B1 (en) * 2004-09-16 2006-11-17 Biomerieux Sa METHOD OF DETECTING STREPTOCOCCUS AGALACTIAE USING ALPHA-GLUCOSIDASE ACTIVITY
DK1828411T3 (en) 2004-12-03 2013-02-18 Human Genetic Signatures Pty Process for simplifying microbial nucleic acids by chemically modifying cytosines
WO2006088860A2 (en) * 2005-02-14 2006-08-24 Beattie Kenneth L Universal fingerprinting chips and uses thereof
WO2006094238A2 (en) 2005-03-03 2006-09-08 Isis Pharmaceuticals, Inc. Compositions for use in identification of adventitious viruses
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
WO2006101913A2 (en) * 2005-03-18 2006-09-28 Eragen Biosciences, Inc. Methods for detecting multiple species and subspecies of neiserria
US20060210999A1 (en) * 2005-03-18 2006-09-21 Verena Grimm Microarray and method for genotyping SHV beta lactamases
US20060210998A1 (en) * 2005-03-18 2006-09-21 Christiane Kettlitz Determination of antibiotic resistance in staphylococcus aureus
US20060246463A1 (en) * 2005-04-20 2006-11-02 Vevea Dirk N Methods and oligonucleotides for the detection of Salmonella SP., E coli 0157:H7, and Listeria monocytogenes
US20060240442A1 (en) * 2005-04-20 2006-10-26 Vevea Dirk N Methods and oligonucleotides for the detection of Salmonella SP., E coli 0157:H7, and Listeria monocytogenes
US8431347B2 (en) 2005-05-26 2013-04-30 Human Genetic Signatures Pty Ltd Isothermal strand displacement amplification using primers containing a non-regular base
US8486629B2 (en) 2005-06-01 2013-07-16 Bioarray Solutions, Ltd. Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
AU2006272776B2 (en) 2005-07-21 2012-01-19 Ibis Biosciences, Inc. Methods for rapid identification and quantitation of nucleic acid variants
AU2006292033B2 (en) 2005-09-14 2010-08-12 Human Genetic Signatures Pty Ltd Assay for a health state
US11834720B2 (en) 2005-10-11 2023-12-05 Geneohm Sciences, Inc. Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx
CN1814797B (en) * 2005-12-02 2012-09-19 浙江大学 Method for identifying 28 frequent phathogenic bacteria for clinical bacteremia
US8088582B2 (en) 2006-04-06 2012-01-03 Ibis Biosciences, Inc. Compositions for the use in identification of fungi
KR100741375B1 (en) 2006-07-24 2007-07-27 대한민국 - Multiplex PCR method for rapid classification of ESBL and PCR primer for PCR method
AT504194B1 (en) * 2006-09-07 2008-07-15 Oesterr Rotes Kreuz BACTERIA DETECTION
EP2064332B1 (en) 2006-09-14 2012-07-18 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
WO2008104002A2 (en) 2007-02-23 2008-08-28 Ibis Biosciences, Inc. Methods for rapid forensic dna analysis
ES2748134T3 (en) 2007-04-04 2020-03-13 Ande Corp Systems for rapid multiple amplification of target nucleic acids
EP2150625B1 (en) * 2007-04-19 2013-03-20 Molecular Detection Inc. Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
US9096849B2 (en) * 2007-05-21 2015-08-04 The United States Of America, As Represented By The Secretary Of The Navy Solid phase for capture of nucleic acids
WO2008151023A2 (en) 2007-06-01 2008-12-11 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
US20090305252A1 (en) * 2007-06-05 2009-12-10 Yihong Li Methods and species-specific primers for detection and quantification of Streptococcus mutans and Streptococcus sanguinis in mixed bacterial samples
EP2183391A4 (en) * 2007-07-31 2010-10-27 Quest Diagnostics Invest Inc Detection of methicillin-resistant and methicillin-sensitive staphylococcus aureus in biological samples
FR2922896B1 (en) * 2007-10-30 2011-04-15 Biomerieux Sa BIOCHEMICAL TEST TO CONFIRM THE PRESENCE OF L.MONOCYTOGENES
EP2215250B1 (en) 2007-11-27 2013-02-27 Human Genetic Signatures Pty Ltd Enzymes for amplification and copying bisulphite modified nucleic acids
FI20075976A0 (en) 2007-12-31 2007-12-31 Finnzymes Oy Methods and oligonucleotides for detecting bacteria that cause mastitis
US8534447B2 (en) 2008-09-16 2013-09-17 Ibis Biosciences, Inc. Microplate handling systems and related computer program products and methods
EP2347254A2 (en) 2008-09-16 2011-07-27 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
WO2010033599A2 (en) 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, systems, and methods
US20100112643A1 (en) * 2008-11-04 2010-05-06 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Method for direct capture of ribonucleic acid
GB0901707D0 (en) * 2009-02-03 2009-03-11 Q Chip Ltd Assay products, devices and method
WO2010093943A1 (en) 2009-02-12 2010-08-19 Ibis Biosciences, Inc. Ionization probe assemblies
JP5600880B2 (en) * 2009-03-03 2014-10-08 東洋紡株式会社 Improved amplification reagents
WO2010104798A1 (en) 2009-03-08 2010-09-16 Ibis Biosciences, Inc. Bioagent detection methods
JP5593037B2 (en) * 2009-03-12 2014-09-17 東洋水産株式会社 Bacteria measurement primer and bacteria measurement method
WO2010114842A1 (en) 2009-03-30 2010-10-07 Ibis Biosciences, Inc. Bioagent detection systems, devices, and methods
US9550985B2 (en) 2009-06-15 2017-01-24 Netbio, Inc. Methods for forensic DNA quantitation
WO2011008971A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Lift and mount apparatus
US9194877B2 (en) 2009-07-17 2015-11-24 Ibis Biosciences, Inc. Systems for bioagent indentification
WO2011014811A1 (en) 2009-07-31 2011-02-03 Ibis Biosciences, Inc. Capture primers and capture sequence linked solid supports for molecular diagnostic tests
EP3098325A1 (en) 2009-08-06 2016-11-30 Ibis Biosciences, Inc. Non-mass determined base compositions for nucleic acid detection
EP2473630B1 (en) * 2009-09-04 2017-11-08 QIAGEN GmbH Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of vancomycin resistance genes and vancomycin resistant enterococci
US9890408B2 (en) 2009-10-15 2018-02-13 Ibis Biosciences, Inc. Multiple displacement amplification
WO2011115840A2 (en) 2010-03-14 2011-09-22 Ibis Biosciences, Inc. Parasite detection via endosymbiont detection
JP2011223940A (en) * 2010-04-21 2011-11-10 Asahi Breweries Ltd Pcr test method for eliminating false-negative, and primer used in the same
WO2012138470A2 (en) 2011-04-04 2012-10-11 Intelligent Medical Devices, Inc. Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantitation, monitoring, screening, and sequencing of group b streptococcus
EP2707509A4 (en) 2011-05-12 2014-11-26 Netbio Inc Methods and compositions for rapid multiplex amplification of str loci
KR101912488B1 (en) 2011-09-07 2018-10-26 휴먼 제네틱 시그너처스 피티와이 엘티디 Molecular detection assay
US20140242587A1 (en) * 2011-10-03 2014-08-28 University Of Florida Research Foundation, Inc. Rapid and Reliable Detection of Infectious Agents
WO2013086201A1 (en) 2011-12-06 2013-06-13 Dowd Scot E Universal or broad range assays and multi-tag sample specific diagnostic process using non-optical sequencing
KR102535489B1 (en) 2014-06-13 2023-05-22 큐-리네아 에이비 Method for detecting and characterising a microorganism
CA2959992A1 (en) * 2014-09-04 2016-03-10 Theranos, Inc. Pathogen and antimicrobial resistance testing
CN104313167A (en) * 2014-10-31 2015-01-28 广东医学院 Primers and method for rapidly identifying group B streptococcus and detecting drug resistance thereof and primer application
GB201507026D0 (en) 2015-04-24 2015-06-10 Linea Ab Q Medical sample transportation container
WO2017044880A1 (en) * 2015-09-09 2017-03-16 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics infectious disease and other health conditions associated with antibiotic usage
CN105936931A (en) * 2016-04-15 2016-09-14 山东畜牧兽医职业学院 Kit for fluorescence quantitative PCR detection of poultry-farm enterobacteriaceae drug-resistant gene and detection method thereof
GB2554767A (en) 2016-04-21 2018-04-11 Q Linea Ab Detecting and characterising a microorganism
CN110062623A (en) * 2016-11-01 2019-07-26 合成生物制品有限公司 For weakening the method and composition of antibiotic resistance
CN106480219A (en) * 2016-12-15 2017-03-08 贵州大学 A kind of poultry staphylococcuses Macrocyclolactone lactone kind medicine drug resistant gene multiple PCR detection kit and using method
CN108456738B (en) * 2017-05-15 2021-08-31 中国农业科学院兰州兽医研究所 Method for detecting staphylococcus saprophyticus by TaqMan real-time fluorescent quantitative PCR
CN110129459B (en) * 2018-02-05 2023-02-24 首都医科大学附属北京朝阳医院 LAMP primer combination for detecting 5 gram-positive bacteria in intraocular fluid and application
CN108624704B (en) * 2018-06-22 2021-08-10 上海孚清生物科技有限公司 Method and kit for combined detection of chlamydia trachomatis, gonococcus and mycoplasma genitalium by fluorescent quantitative PCR probe technology
CN112930228A (en) * 2018-09-03 2021-06-08 维斯比医学公司 Apparatus and method for antibiotic susceptibility testing
CN109402277A (en) * 2018-12-13 2019-03-01 博奥生物集团有限公司 For quickly detecting the LAMP primer composition and application of enterococcus faecalis and enterococcus faecium
CN111693657A (en) * 2019-03-15 2020-09-22 烟台欣和企业食品有限公司 Method for evaluating preservative capability of seasoning
AU2020296183A1 (en) * 2019-06-19 2022-01-27 T2 Biosystems, Inc. Methods and compositions for comprehensive and high sensitivity detection of pathogens and drug resistance markers
CN110257540A (en) * 2019-07-23 2019-09-20 中国疾病预防控制中心传染病预防控制所 Detect PCR primer, primer sets, probe and its kit and detection method of Proteus and proteus mirabilis
CN110951895B (en) * 2019-12-24 2021-03-23 重庆市畜牧科学院 System and method for detecting and distinguishing proteus mirabilis, proteus vulgaris and proteus pani
CN111705118B (en) * 2020-06-23 2023-01-10 宁夏医科大学总医院 Blood stream infection detection kit based on target gene high-throughput sequencing
EP4294521A1 (en) * 2021-02-17 2023-12-27 Cap Diagnostics, LLC, DBA Pathnostics Methods and systems for determining suitability of compositions for inhibiting growth of polymicrobial samples
CN112863606B (en) * 2021-03-08 2022-07-26 杭州微数生物科技有限公司 Genome database for bacterium identification and typing analysis and identification and typing analysis method
WO2022253743A1 (en) 2021-06-02 2022-12-08 Syngulon S.A. Bacteriocin for new application
WO2022253741A1 (en) 2021-06-02 2022-12-08 Syngulon S.A. Cerein 7b bacteriocin for new application
CN113493847B (en) * 2021-06-24 2022-04-19 北京工业大学 Antibiotic resistance gene based on PMA high-throughput sequencing and PICRUSt and identification method of potential host bacteria
CN113481310B (en) * 2021-07-27 2023-05-05 河北农业大学 LAMP primer group and LAMP kit for detecting ginger rot pathogen and application of LAMP primer group and LAMP kit
CN113817810A (en) * 2021-08-09 2021-12-21 宁波大学 Novel qPCR (quantitative polymerase chain reaction) method for detecting lactic acid bacteria in fermented milk
WO2023049273A1 (en) * 2021-09-22 2023-03-30 Biomedit, Llc Methods for preserving healthy intestinal microbiome during growth promoter administration
WO2023081770A1 (en) * 2021-11-03 2023-05-11 T2 Biosystems, Inc. Methods and systems for amplification and detection in biological samples
CN114214399A (en) * 2021-12-17 2022-03-22 山东博弘基因科技有限公司 Urea ureaplasma urealyticum PCR detection kit
WO2024036158A1 (en) * 2022-08-08 2024-02-15 North Carolina State University Methods and compositions for detecting the fungal pathogen ceratocystis fimbriata
CN116287330B (en) * 2022-12-30 2023-12-05 中国科学院生态环境研究中心 High-flux real-time fluorescent quantitative PCR chip capable of detecting multiple virulence genes and detection method thereof

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71715A0 (en) * 1983-08-05 1984-09-30 Miles Lab Method,gene probes and test kit for detecting bacteria by nucleic acid hybridization
FR2567541B1 (en) * 1984-07-13 1987-02-06 Pasteur Institut DNA PROBE AND METHOD FOR THE DETECTION OF "SHIGELLES" AND ENTERO-INVASIVE STRAINS OF ESCHERICHIA COLI
FR2584419B1 (en) * 1985-07-08 1987-11-13 Pasteur Institut PROBE AND METHOD FOR DETECTING FACTORS OF RESISTANCE TO ERYTHROMYCIN IN CELL CULTURES, ESPECIALLY BACTERIAL
FR2599743B1 (en) * 1986-06-10 1988-09-30 Pasteur Institut DNA FRAGMENT COMPRISING AT LEAST ONE PART OF AN ERYTHROMYCIN RESISTANCE GENE, METHOD FOR OBTAINING SAME AND BIOCHEMICAL APPLICATIONS THEREOF
WO1988000618A1 (en) * 1986-07-10 1988-01-28 Toray Industries, Inc. Method of inspecting specimen for bacteria and probe therefor
WO1988003957A1 (en) * 1986-11-24 1988-06-02 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms
DE3718591A1 (en) * 1987-06-03 1988-12-15 Behringwerke Ag AEUSSERES MEMBRANE PROTEIN F BY PSEUDOMONAS AERUGINOSA
US5089386A (en) 1987-09-11 1992-02-18 Gene-Trak Systems Test for listeria
WO1989006699A1 (en) * 1988-01-13 1989-07-27 Institut Pasteur Dna probe specific for hemolytic listeria
EP0337896B1 (en) 1988-04-15 1993-07-28 N.V. Innogenetics S.A. Hybridization probes for detecting neisseria strains
US5523205A (en) * 1988-08-02 1996-06-04 Institut Pasteur DNA probes specific for hemolytic listeria
US5084565A (en) * 1988-08-18 1992-01-28 Gene-Trak Systems Probes for the specific detection of escherichia coli and shigella
FR2636075B1 (en) * 1988-09-07 1991-11-15 Biotechnologie Ste Europ METHOD FOR DETECTING BACTERIA, YEAST, PARASITES AND OTHER EUKARYOTS, ESPECIALLY IN FOOD PRODUCTS
US5041372A (en) * 1988-11-02 1991-08-20 The United States Of America As Represented By The Department Of Health And Human Services Probe to identify enteroinvasive E. coli and Shigella species
US5030556A (en) * 1989-03-30 1991-07-09 Danielle Beaulieu Species-specific DNNA probe for the detection of Branhamella catarrhalis
DE69022167T2 (en) * 1989-05-23 1996-02-15 Amoco Corp NUCLEIC ACID PROBE FOR DETECTING STAPHYLOCOCCUS AUREUS.
ATE127530T1 (en) * 1989-05-31 1995-09-15 Amoco Corp UNIVERSAL NUCLEIC ACID PROBE FOR EUBACTERIA AND METHODS.
DE3925613A1 (en) 1989-06-22 1991-01-03 Boehringer Mannheim Gmbh NEISSERIA-SPECIFIC DNA PROBE
US5334501A (en) * 1989-07-11 1994-08-02 Microprobe Corporation Quantification of bacteria using a nucleic acid hybridization assay
NL9002157A (en) * 1989-11-27 1991-06-17 U Gene Research Bv DNA FRAGMENTS AND DNA PROBES AND PRIMERS BASED ON THAT.
CA2033718A1 (en) * 1990-01-19 1991-07-20 Ronald M. Atlas Process for detection of water-borne microbial pathogens and indicators of human fecal contamination in water samples and kits therefor
AU7188491A (en) * 1990-02-02 1991-08-21 N.V. Innogenetics S.A. Hybridization probes for the detection of (branhamella catarrhalis) strains
EP0452596A1 (en) * 1990-04-18 1991-10-23 N.V. Innogenetics S.A. Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms
SE466259B (en) * 1990-05-31 1992-01-20 Arne Forsgren PROTEIN D - AN IGD BINDING PROTEIN FROM HAEMOPHILUS INFLUENZAE, AND THE USE OF THIS FOR ANALYSIS, VACCINES AND PURPOSE
EP0479117B1 (en) * 1990-10-05 2001-11-28 F. Hoffmann-La Roche Ag Methods and reagents for identifying gram negative bacteria
CA2104014C (en) * 1991-02-15 2000-05-02 David E. Briles Structural gene of pneumococcal protein
US5980909A (en) * 1991-02-15 1999-11-09 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5472843A (en) * 1991-04-25 1995-12-05 Gen-Probe Incorporated Nucleic acid probes to Haemophilus influenzae
US5232831A (en) * 1991-06-28 1993-08-03 Gen-Probe Incorporated Nucleic acid probes to streptococcus pyogenes
CA2116543C (en) * 1991-07-31 2007-10-02 Kay S. Greisen Methods and reagents for detection of bacteria in cerebrospinal fluid
JPH0549477A (en) * 1991-08-05 1993-03-02 Wakunaga Pharmaceut Co Ltd Detection of bacteria of the genus staphylococcus
CA2075423A1 (en) * 1991-08-13 1993-02-14 Paul Luther Skatrud Rapid method for detection of methicillin resistant staphylococci
US5292874A (en) * 1991-09-04 1994-03-08 Gen-Probe Incorporated Nucleic acid probes to Staphylococcus aureus
FR2685334B1 (en) * 1991-12-23 1995-05-05 Bio Merieux POLYPEPTIDES CONTAINING CHARACTERISTIC SEQUENCES OF PYRROLIDONE CARBOXYLYL PEPTIDASES, POLYNUCLEOTIDES CONTAINING A SEQUENCE ENCODING SUCH POLYPEPTIDES, AND THEIR USE.
JPH0690798A (en) * 1992-02-05 1994-04-05 Toagosei Chem Ind Co Ltd Probe for detecting staphylococcus aureus and method for detecting the same
FR2687168B1 (en) * 1992-02-10 1994-03-25 Bio Merieux FRAGMENT OF STREPTOCOCCUS PNEUMONIAE GENOMIC DNA, HYBRIDIZATION PROBE, AMPLIFIER PRIME, REAGENT AND METHOD FOR DETECTION OF STREPTOCOCCUS PNEUMONIAE.
JPH0654700A (en) * 1992-05-19 1994-03-01 Mitsui Toatsu Chem Inc Highly sensitive detection of resistant bacterium
ATE314467T1 (en) * 1992-07-07 2006-01-15 Fuso Pharmaceutical Ind PROBE FOR DIAGNOSING AN INFECTIOUS DISEASE CAUSED BY STAPHYLOCOCCUS AUREUS
IL106273A0 (en) * 1992-07-17 1993-11-15 Res Dev Foundation Rapid detection of biopolymers in stained specimens
JPH06165681A (en) * 1992-12-02 1994-06-14 Toyobo Co Ltd Oligonucleotide for detection of methicillin resistant staphylococcus aureus, detection of methicillin resistant staphylococcus aureus and kit of detection reagent
FR2699539B1 (en) * 1992-12-18 1995-02-17 Pasteur Institut Protein conferring an inducible type resistance to glycopeptides, especially in gram-positive bacteria. Nucleotide sequence encoding this protein.
WO1995000650A1 (en) * 1993-06-23 1995-01-05 Beckman Instruments, Inc. Recombinant dnase b derived from streptococcus pyogenes
JP3499263B2 (en) * 1993-09-03 2004-02-23 株式会社紀文食品 Detection and nucleotide sequence of Klebsiella spp.
US5426026A (en) * 1993-09-15 1995-06-20 University Of Pittsburgh PCR identification of four medically important candida species using one primer pair and four species-specific probes
US5712118A (en) * 1993-09-29 1998-01-27 Research Foundation Of State University Of New York Vaccine for branhamella catarrhalis
JP3525475B2 (en) * 1994-01-10 2004-05-10 恵 河野 Novel 'mecA protein, DNA encoding the same, and method for detecting methicillin-resistant Staphylococcus aureus using the same
US5582978A (en) * 1994-01-21 1996-12-10 Amoco Corporation Nucleic acid probes for the detection of Haemophilus influenzae
DK0769068T3 (en) * 1994-06-24 2006-02-27 Innogenetics Nv Simultaneous detection, identification and differentiation of eubacterial taxa using a hybridization assay
DE69534747T2 (en) * 1994-07-19 2006-07-06 Wyeth Holdings Corp. HAEMOPHILUS INFLUENZAE (NT HI) LKP TIP ADHESINE PROTEIN AND NUCLEIC ACID
US6001564A (en) * 1994-09-12 1999-12-14 Infectio Diagnostic, Inc. Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US5668263A (en) * 1994-12-16 1997-09-16 Smithkline Beecham Corporation Conserved yeast nucleic acid sequences
US5827515A (en) * 1995-08-30 1998-10-27 Sandoz Ltd. Bacillus thuringiensis sporulation gene
US6737248B2 (en) * 1996-01-05 2004-05-18 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and sequences

Also Published As

Publication number Publication date
DK0943009T3 (en) 2009-10-05
WO1998020157A3 (en) 1998-08-13
EP2336365A1 (en) 2011-06-22
JP2010094133A (en) 2010-04-30
EP2336366B1 (en) 2015-04-15
EP2336364B1 (en) 2015-04-08
CN1248295A (en) 2000-03-22
EP2336365B1 (en) 2014-10-15
NO991976D0 (en) 1999-04-26
NO991976L (en) 1999-07-02
NZ335548A (en) 2001-03-30
EP2339033A1 (en) 2011-06-29
EP2336366A1 (en) 2011-06-22
CA2790915C (en) 2013-12-24
DE69739473D1 (en) 2009-08-06
BR9713494A (en) 2000-02-29
CA2789369A1 (en) 1998-05-14
JP2001504330A (en) 2001-04-03
EP2345746B1 (en) 2014-10-15
JP2008289493A (en) 2008-12-04
EP2336364A1 (en) 2011-06-22
CA2715575C (en) 2012-12-18
ATE434669T1 (en) 2009-07-15
US5994066A (en) 1999-11-30
EP0943009B1 (en) 2009-06-24
WO1998020157A2 (en) 1998-05-14
ATE552352T1 (en) 2012-04-15
JP5221507B2 (en) 2013-06-26
EP0943009A2 (en) 1999-09-22
AU731850B2 (en) 2001-04-05
CA2789369C (en) 2013-05-07
CA2270281A1 (en) 1998-05-14
ES2329202T3 (en) 2009-11-23
EP2345746A1 (en) 2011-07-20
EP2128268B1 (en) 2012-04-04
CA2790915A1 (en) 1998-05-14
CA2270281C (en) 2010-12-21
EP2339034A1 (en) 2011-06-29
AU4859897A (en) 1998-05-29
EP2128268A1 (en) 2009-12-02

Similar Documents

Publication Publication Date Title
CA2715575A1 (en) Method to detect candida species
JP4176146B2 (en) Specific and universal probes and amplification primers for the rapid detection and identification of common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
RU2154106C2 (en) Simultaneous determination, identification and differentiation of eubacterial taxons using hybridization analysis
AU702237B2 (en) Universal targets for species identification
JP3070529B2 (en) Species-specific detection of Mycobacterium kansasii
KR101589483B1 (en) Method for Detection of Nucleic Acids by Asymmetric Isothermal Amplification of Nucleic Acids and Signal Probe
EP1062367A1 (en) Zymogenic nucleic acid detection methods, and related molecules and kits
JP4771755B2 (en) Oligonucleotide, eukaryotic detection method and identification method using oligonucleotide
WO2003014704A2 (en) Rapid and specific detection of campylobacter
JP3048340B2 (en) Materials and methods for species-specific detection of M. kansasii nucleic acids
US8206921B2 (en) Detection of methicillin-resistant Staphylococcus aureus
EP1176215B1 (en) Amplification and detection of mycoplasma pneumoniae
WO2021201072A1 (en) Primer set and probe for detecting staphylococcus argenteus
EP1759017B1 (en) Dna sequences for the detection of and differentiation amongst pathogenic e.coli strains
KR101518561B1 (en) Development of species-specific PCR method for detection of Acinetobacter species
WO2022202954A1 (en) Method for amplifying target gene having specific gc content
JP2004534536A (en) Gram-positive bacteria detection method
WO2024023510A1 (en) Method and kit for detecting single nucleotide polymorphisms (snp) by loop-mediated isothermal amplification (lamp)
AU705198C (en) Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
JPH0789960B2 (en) Oligonucleotide for detection of Staphylococcus aureus and detection method using the same

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20171106